MIVetsCan: Can-Coach Trial (Phase 1)
CompletedNot applicableNCT06320470
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of the MIVetsCan Can-Coach Trial is to pilot and modify a trial of four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.
Study details
- Official title
- MIVetsCan: Cannabis Coaching for Veteran Pain Management Trial (Phase 1)
- Conditions
- Interventions
- Behavioral: Educational Session
- Sponsor
- University of Michigan
- Collaborators
- Michigan, State of, Licensing and Regulatory Affairs
- Start date
- 2023-08-07
- Primary completion
- 2023-12-11
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * United States Veteran * Experiencing chronic pain (pain lasting 3 or more months) * Worst pain of ≥3 out of 10 using a 0-10 Numeric Rating Scale (NRS) * Are planning or currently using cannabidiol (CBD) or cannabis products for pain management * Able to read and speak English sufficiently to allow for informed consent and active participation in the educational intervention sessions * Willingness to attend all study visits (conducted virtually) * Willingness to fill out periodic assessments via smartphone to assess symptom status and cannabis use (protocol has more details) Exclusion Criteria: * Inability to provide informed consent (e.g., cognitive impairment, unable to sufficiently communicate in English) * Participant states participant is pregnant * Current diagnosis or past history of a psychotic disorder (schizophrenia spectrum, except substance/medication -induced or due to another condition) * Current diagnosis or past history of bipolar disorder * Unable to attend study visits * Risk for eminent harm - Suicidal ideation or wish to die as assessed with the Positive and Negative Suicide Ideation (PANSI) questionnaire and further risk assessment by study team members * Any impairment, activity, behavior, or situation that in the judgment of the study team would prevent satisfactory completion of the study protocol
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06320470